INMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 146.3% based on the discounted cash flow analysis.
| Market cap | $878.31 Million |
|---|---|
| Enterprise Value | $505.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.45 |
| Beta | 1.91 |
| Outstanding Shares | 63,401,000 |
| P/E Ratio | 11.07 |
|---|---|
| PEG | -30.36 |
| Price to Sales | 2.98 |
| Price to Book Ratio | 1.49 |
| Enterprise Value to Revenue | 1.35 |
| Enterprise Value to EBIT | 5.16 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 205.69% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.27%▼ 51.60% |
|---|---|
| Total Invested | $2.51M▼ 99.45% |
| Investors Holding | 5▼ 197.00% |
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...